“The Cost-Effectiveness of Losartan in Type 2 Diabetics With Nephropathy in Switzerland - an Analysis of the RENAAL Study”. Swiss Medical Weekly, vol. 134, no. 3132, Aug. 2004, pp. 440-7, https://doi.org/10.4414/smw.2004.10492.